There are still lots of open positions. Let's find the one that's right for you.
The Kung Lab is seeking a highly motivated and successful individual who should be highly proficient in a variety of molecular and cellular biology techniques and have a strong fundamental knowledge of cancer genetics and epigenetics. Candidates with experience in cellular therapy development (e.g., CAR-T, BiTE, TCR) is highly desired. Experience with next generation sequencing (WGS, RNAseq, ChIP-seq), gene editing (CRISPR), and/or mouse cancer models (transgenic or xenograft models) are also desired. The candidate will lead the development and evaluation of cell therapy-based approaches with the goal of translating promising constructs into the clinic for the treatment of pediatric cancer. The laboratory headed by Dr. Andrew Kung, located in the Mortimer B. Zuckerman Research Center, focuses on translational research with the overarching goal of credentialing new therapeutic targets, identifying molecular biomarkers of response, and validating targeted therapeutic strategies for pediatric malignancies.